Jeffrey A. Knauf

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Edna Teruko Kimura, Marina N. Nikiforova, Zhaowen Zhu et al. · PubMed · 2003 · 1.5K citations

Medicine, Genetics, Oncology +17

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai et al. · Journal of Clinical Investigation · 2016 · 1.3K citations · Full text

Life Sciences, Genetics, Oncology +17

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

Marina N. Nikiforova, Edna Teruko Kimura, Manoj Gandhi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Rebecca E. Schweppe, Joshua Klopper, Christopher Korch et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 565 citations · Full text

Medicine, Genetics, Molecular Biology +12

Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i>

Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale et al. · Cancer Research · 2009 · 527 citations · Full text

Medicine, Genetics, Oncology +17